Catalytic antibodies. How to promote proton transfer

Optimal N-caps for N-terminal helical templates: effects of changes in H-bonding efficiency and charge.

Journal of the American Chemical Society·2001

Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers.

Biochemistry·2001

Template-nucleated alanine-lysine helices are stabilized by position-dependent interactions between the lysine side chain and the helix barrel.

Proceedings of the National Academy of Sciences of the United States of America·1996

Novel class of silicon-based protective groups for the side chain of tyrosine.

International journal of peptide and protein research·1993

Resolution of proline acylation problem for thiol capture strategy by use of a chloro-dibenzofuran template.

International journal of peptide and protein research·1992

The helical s constant for alanine in water derived from template-nucleated helices.

Nature·1991

Wake-activated neuronal populations that regulate sleep drive.

Nature·2026

Observation of conformal field theory spectra in a quantum simulator.

Nature·2026

Human brain organoids record the passage of time over multiple years.

Nature·2026

Discovery of a star sensitive to the spin of Sagittarius A.

Nature·2026

Asymmetric prefrontal representations for leader-follower dynamics.

Nature·2026

Family genetic designs in MoBa provide insights into health and functioning.

Nature·2026

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Related Experiment Videos

Catalytic antibodies. How to promote proton transfer

Related Concept Videos

Optimal N-caps for N-terminal helical templates: effects of changes in H-bonding efficiency and charge.

Short, solubilized polyalanines are conformational chameleons: exceptionally helical if N- and C-capped with helix stabilizers, weakly to moderately helical if capped with rigid spacers.

Template-nucleated alanine-lysine helices are stabilized by position-dependent interactions between the lysine side chain and the helix barrel.

Novel class of silicon-based protective groups for the side chain of tyrosine.

Resolution of proline acylation problem for thiol capture strategy by use of a chloro-dibenzofuran template.

The helical s constant for alanine in water derived from template-nucleated helices.

Wake-activated neuronal populations that regulate sleep drive.

Observation of conformal field theory spectra in a quantum simulator.

Human brain organoids record the passage of time over multiple years.

Discovery of a star sensitive to the spin of Sagittarius A.

Asymmetric prefrontal representations for leader-follower dynamics.

Family genetic designs in MoBa provide insights into health and functioning.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Related Experiment Videos

Catalytic antibodies. How to promote proton transfer

Related Concept Videos

Related Articles